北京大学学报(医学版) ›› 2020, Vol. 52 ›› Issue (4): 621-624. doi: 10.19723/j.issn.1671-167X.2020.04.004

• 论著 • 上一篇    下一篇

14例恶性潜能未定的前列腺间质肿瘤病例分析

刘毅1,刘志坚1,沈棋1,吴静云2,范宇1,李德润1,虞巍1,何志嵩1,()   

  1. 1.北京大学第一医院泌尿外科,北京大学泌尿外科研究所,国家泌尿男性生殖系肿瘤研究中心,北京 100034
    2.北京大学第一医院影像科,北京 100034
  • 收稿日期:2020-03-31 出版日期:2020-08-18 发布日期:2020-08-06
  • 通讯作者: 何志嵩 E-mail:hezhisong901@163.com

A clinical analysis of 14 cases of prostatic stromal tumor of uncertain malignant potential

Yi LIU1,Zhi-jian LIU1,Qi SHEN1,Jing-yun WU2,Yu FAN1,De-run LI1,Wei YU1,Zhi-song HE1,()   

  1. 1. Department of Urology, Peking University First Hospital; Institute of Urology, Peking University; National Urological Cancer Center, Beijing 100034, China
    2. Department of Radiology, Peking University First Hospital, Beijing 100034, China
  • Received:2020-03-31 Online:2020-08-18 Published:2020-08-06
  • Contact: Zhi-song HE E-mail:hezhisong901@163.com

RICH HTML

  

摘要:

目的: 探讨恶性潜能未定的前列腺间质肿瘤(stromal tumor of uncertain malignant potential,STUMP)的临床及影像学表现、病理特点、治疗及预后情况。方法: 回顾性分析2008年10月至2020年4月北京大学第一医院泌尿外科诊治的14例STUMP患者的临床资料,年龄27~78岁(平均54岁), 病程1~180个月(平均46个月)。以排尿困难、尿路刺激症状为主要表现,直肠指诊可提示前列腺肿物,血清前列腺特异性抗原(prostate specific antigen, PSA)正常或轻度升高,经直肠超声及磁共振提示前列腺肿瘤或前列腺增生结节。结果: 3例仅行前列腺穿刺活检术,2例仅行经尿道前列腺切除术,9例经病理明确诊断后行根治性前列腺切除术或经尿道前列腺切除术。镜下观察前列腺间质细胞过度增生,呈梭形细胞,细胞异型性不明显,核分裂像少见。免疫组织化学检查,PSA均为阴性,波形蛋白均为阳性,CD34及孕激素受体多呈阳性,Ki67阳性指数为1%~20%(平均6%)。病理诊断为恶性潜能未定的前列腺间质肿瘤。随访时间10~96个月(平均65个月), 失访2例,死亡1例,9例术后未见复发,2例因局部复发而多次行经尿道前列腺切除术。结论: STUMP的影像学表现具有特征性,可通过前列腺穿刺活检获得病理学诊断;早期发现确诊,结合临床制定手术为主的综合治疗方案,有助于改善患者预后。

关键词: 前列腺肿瘤, 恶性潜能未定的前列腺间质肿瘤, 病理学

Abstract:

Objective: To investigate the clinical and pathologic characteristics, diagnosis, treatment, prognosis and survival of prostatic stromal tumor of uncertain malignant potential. Methods: Overall 14 patients with prostatic stromal tumor of uncertain malignant potential were treated from October 2008 to April 2020, the patient age ranged from 27 to 78 years (mean 54 years). The disease duration was 1 to 180 months (mean duration of 46 months). The clinical manifestations mainly included urinary obstructive symptoms and urethral irritating symptoms. The tumors were located in the peripheral zone or the transition zone. Digital rectum examination indicated prostatic tumor. Serum prostatic specific antigen level was always normal or elevated. Transrectal ultrasonography and magnetic resonance imaging indicated prostatic tumor. Magnetic resonance imaging in showed large, round, well-defined masses, which were diffusely heterogeneous signal on T2 weighted imaging. Following the administration of intravenous contrast medium, the lesion had diffuse and heterogeneous enhancement. Results: In the study, 3 cases underwent prostate biopsy, 2 cases underwent transurethral resection of the prostate, 9 cases underwent radical excision or transurethral resection of the prostate with definite diagnosis of pathologic features. Under the light microscope, the interstitial cells of stromal tumor of uncertain malignant potential were overgrowth and fusiform cells showed some degree of pleomorphism, nuclei with few mitotic figures, and necrosis was not often seen. Immunohistochemical staining showed that prostate specific antigen was negative, while vimentin was positive in the tumor tissue, CD34, progesterone receptor and smooth muscle actin were positive in the majority, and Ki67 positive index was 1%-20% (mean 6%). Twelve cases were followed-up, and the time of survival varied from 10 to 96 months (mean 65 months), two cases were lost to the follow-up, one case died of disease at the end of 10 months, nine cases were free of disease recurrence after surgery, two cases underwent more transurethral resection of the prostate due to local recurrence. Conclusion: STUMP is a very rare tumor of the specialized prostatic stroma with an unpredictable clinical behavior. The clinical manifestations, transrectal ultrasonography and magnetic resonance imaging are valuable for the diagnosis of prostatic stromal tumor of uncertain malignant potential. Its definite diagnosis depends on pathological examination. Up to now, early surgery and combined therapy are effective treatments for prostatic stromal tumor of uncertain malignant potential.

Key words: Prostatic neoplasms, Stromal tumor of uncertain malignant potential, Pathology

中图分类号: 

  • R737.25

图1

恶性潜能未定的前列腺间质肿瘤影像学表现"

图2

恶性潜能未定的前列腺间质肿瘤病理学特征"

[1] Gaudin PB, Rosai J, Epstein JI. Sarcomas and related proliferative lesions lesions of specialized prostatic stroma: a clinicopathologic study of 22 cases[J]. Am J Surg Pathol, 1998,22(2):148-162.
pmid: 9500215
[2] Herawi M, Epstein JI. Specialized stromal tumors of the peostate: a clinicopathologic study of 50 cases[J]. Am J Surg Pathol, 2006,30(6):694-704.
doi: 10.1097/00000478-200606000-00004 pmid: 16723846
[3] 李超, 王慕文. 恶性潜能未定的前列腺间质肿瘤的临床特点及诊疗策略[J]. 泌尿外科杂志(电子版), 2013,5(4):25-27.
[4] Humphrey PA, Moch H, Cubilla AL, et al. The 2016 WHO classification of tumours of the urinary system and male genital organs-part B: postate and bladder tumours[J]. Eur Urol, 2016,70(1):106-119.
pmid: 26996659
[5] Murer LM, Talmon GA. Stromal tumor of uncertain malignant potential of the prostate[J]. Arch Pathol Lab Med, 2014,138(1):1542-1545.
[6] Muglia VF, Saber G, Maggioni G, et al. MRI findings of prostate stromal tumor of uncertain malignant potential: a case report[J]. Br J Radiol, 2011,84(1006):e194-e196.
pmid: 21933974
[7] Shabaik A. Nonepithelial tumors and tumor-like lesions of the prostate gland[J]. Crit Rev Clin Lab Sci, 2003,40(4):429-472.
doi: 10.1080/10408360390247823 pmid: 14582603
[8] Tavora F, Kryvenko ON, Epstein JI. Mesenchymal tumours of the bladder and prostate: an update[J]. Pathology, 2013,45(2):104-115.
doi: 10.1097/PAT.0b013e32835c768b pmid: 23250042
[1] 李志存, 吴天俣, 梁磊, 范宇, 孟一森, 张骞. 穿刺活检单针阳性前列腺癌术后病理升级的危险因素分析及列线图模型构建[J]. 北京大学学报(医学版), 2024, 56(5): 896-901.
[2] 田宇轩,阮明健,刘毅,李德润,吴静云,沈棋,范宇,金杰. 双参数MRI改良PI-RADS评分4分和5分病灶的最大径对临床有意义前列腺癌的预测效果[J]. 北京大学学报(医学版), 2024, 56(4): 567-574.
[3] 姚凯烽,阮明健,李德润,田宇轩,陈宇珂,范宇,刘毅. 靶向穿刺联合区域系统穿刺对PI-RADS 4~5分患者的前列腺癌诊断效能[J]. 北京大学学报(医学版), 2024, 56(4): 575-581.
[4] 欧俊永,倪坤明,马潞林,王国良,颜野,杨斌,李庚午,宋昊东,陆敏,叶剑飞,张树栋. 肌层浸润性膀胱癌合并中高危前列腺癌患者的预后因素[J]. 北京大学学报(医学版), 2024, 56(4): 582-588.
[5] 薛蔚,董樑,钱宏阳,费笑晨. 前列腺癌新辅助治疗与辅助治疗的现状及进展[J]. 北京大学学报(医学版), 2023, 55(5): 775-780.
[6] 刘毅,袁昌巍,吴静云,沈棋,肖江喜,赵峥,王霄英,李学松,何志嵩,周利群. 靶向穿刺+6针系统穿刺对PI-RADS 5分患者的前列腺癌诊断效能[J]. 北京大学学报(医学版), 2023, 55(5): 812-817.
[7] 毛海,张帆,张展奕,颜野,郝一昌,黄毅,马潞林,褚红玲,张树栋. 基于MRI前列腺腺体相关参数构建腹腔镜前列腺癌术后尿失禁的预测模型[J]. 北京大学学报(医学版), 2023, 55(5): 818-824.
[8] 袁昌巍,李德润,李志华,刘毅,山刚志,李学松,周利群. 多参数磁共振成像中动态对比增强状态在诊断PI-RADS 4分前列腺癌中的应用[J]. 北京大学学报(医学版), 2023, 55(5): 838-842.
[9] 时云飞,王豪杰,刘卫平,米岚,龙孟平,刘雁飞,赖玉梅,周立新,刁新婷,李向红. 血管免疫母细胞性T细胞淋巴瘤临床与分子病理学特征分析[J]. 北京大学学报(医学版), 2023, 55(3): 521-529.
[10] 李挺. 建设当代临床病理学科[J]. 北京大学学报(医学版), 2023, 55(2): 197-200.
[11] 周桥. 肿瘤病理学研究的进展和展望[J]. 北京大学学报(医学版), 2023, 55(2): 201-209.
[12] 沈棋,刘亿骁,何群. 肾黏液样小管状和梭形细胞癌的临床病理特点及预后[J]. 北京大学学报(医学版), 2023, 55(2): 276-282.
[13] 侯卫华,宋书杰,石中月,金木兰. 幽门螺杆菌阴性早期胃癌的临床病理特征[J]. 北京大学学报(医学版), 2023, 55(2): 292-298.
[14] 刘菊梅,梁丽,张继新,戎龙,张梓怡,吴悠,赵旭东,李挺. 411例早期胃癌及癌前病变内镜黏膜下剥离术标本的病理学评估[J]. 北京大学学报(医学版), 2023, 55(2): 299-307.
[15] 农琳,王微,梁丽,李东,李鑫,李挺. 母细胞性浆样树突细胞肿瘤13例临床病理学特征[J]. 北京大学学报(医学版), 2023, 55(2): 308-314.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!